Detalhe da pesquisa
1.
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.
J Pathol
; 263(2): 242-256, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578195
2.
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Prostate
; 84(7): 623-635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450798
3.
New approaches to targeting epigenetic regulation in prostate cancer.
Curr Opin Urol
; 32(5): 472-480, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869742
4.
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
SLAS Discov
; 26(9): 1107-1124, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111999
5.
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.
Mol Cancer Ther
; 20(11): 2140-2150, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413130
6.
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
Nat Commun
; 12(1): 5049, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413304
7.
Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer.
Front Oncol
; 10: 581515, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33134178